MGRX · Mangoceuticals Inc
United States · RS rating 8 · As of 2026-11-03
| Price | 0.22 USD |
|---|---|
| 1-day change | -4.4% |
| RS rating (overall / 1M / 3M / 12M) | 8 / 5 / 9 / 5 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 32 / 10 / 51 |
| Industry group (rank) | Medical-Generic Drugs (136) |
| EPS growth Q/Q | +59.1% |
| Sales growth Q/Q | +12.0% |
| Distance from 52-week high | +90.1% |
| Market cap (USD) | $6.9M |